Medline Inc. (MDLN) stock
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3066% above fair value
$39.47−0.51 (-1.28%)
Close on Nov 13, 2026Market cap $51.89BP/E –Yield –
Medline gross margin
Gross margin is gross profit as a percentage of revenue.
Medline's gross margin for the twelve months ending Sep 26, 2026 was 25.7%. For fiscal 2025 it was 26.4%, against 27.3% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 26.4% | −0.9 |
| FY2024 | Dec 31, 2024 | 27.3% | +2.0 |
| FY2023 | Dec 31, 2023 | 25.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | 24.5% | −1.8 |
| Q2 FY2026 | Jun 27, 2026 | 28.8% | +1.2 |
| Q1 FY2026 | Mar 28, 2026 | 25.0% | −2.4 |
| Q4 FY2025 | Dec 31, 2025 | 24.6% | – |
| Q3 FY2025 | Sep 27, 2025 | 26.4% | – |
| Q2 FY2025 | Jun 28, 2025 | 27.7% | – |
| Q1 FY2025 | Mar 29, 2025 | 27.5% | – |
See a number that looks wrong?